This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.
Spirulina
Cyanobacterial whole-food supplement (Arthrospira platensis/maxima), 55-70% complete protein with the unusual pigment-protein phycocyanin driving most pharmacological effects: modest BP reduction (…
Aliases (9)
Overview
What is Spirulina?
Cyanobacterial whole-food supplement (Arthrospira platensis/maxima), 55-70% complete protein with the unusual pigment-protein phycocyanin driving most pharmacological effects: modest BP reduction (~4 mmHg SBP per 2024-25 GRADE meta-analyses), lipid improvement (LDL/TC/TG ↓, HDL ↑), allergic rhinitis symptom relief (Cingi 2008), and small ergogenic endurance gains (Kalafati 2010). Real food-grade value for plant-based diets needing iron + protein. For Dylan (20yo MMA athlete with adequate diet, no allergic rhinitis, no BP/lipid issue) it's LOW priority — protein is already covered, microcystin/heavy-metal contamination risk in non-tested product is a hard block, and per-gram-protein cost is much worse than whey or pea. OPTIONAL-ADD only if buying Hawaiian Spirulina Pacifica (Cyanotech) or equivalent COA-certified product at 3-6 g/day for general antioxidant/greens-replacement use. Skip in PKU, autoimmune flare, or if no COA is available.
Research Indications
Antioxidant mechanism
C-PC directly scavenges peroxyl, hydroxyl, and alkoxyl radicals via the bilin chromophore; inhibits NADPH oxidase (the major non-mitochon…
Anti-inflammatory mechanism
Selective COX-2 inhibition (Reddy et al. 2000 demonstrated phycocyanin IC50 ~180 nM at COX-2, ~1.3% inhibition at COX-1 — striking select…
Antihypertensive mechanism
Direct ACE inhibition by phycocyanin peptide fragments (multiple studies); enhances endothelial nitric oxide synthesis; reduces angiotens…
Immunomodulatory mechanism
Increases NK-cell activity, IL-2 production, and macrophage phagocytic capacity in mouse models; this is also why active autoimmune disea…
Practical
Do NOT rely on spirulina for B12 status. Vegans should still supplement methylcobalamin or cyanocobalamin separately. This issue is share…
Research Protocols
Disclaimer: These are commonly discussed research protocols and not medical advice.
Peptide Interactions
enhances iron absorption from spirulina; recommended co-administration if using for iron support.
complements spirulina's GLA + ALA fatty-acid profile; combined anti-inflammatory effect.
common stacker among community users (dopamine.club: 81 co-mentions with D3). No pharmacokinetic interaction; both general-health basal supplements.
additive antioxidant + anti-inflammatory mechanisms (Nrf2 pathway, COX-2 inhibition).
2025 cardiometabolic meta found spirulina + exercise outperformed spirulina alone for HDL-C, LDL-C, and body composition.
pepper's piperine may modestly enhance phycocyanin bioavailability (mechanism: CYP inhibition + intestinal absorption modulation); evidence weak but plausible.
risk of cumulative iron overload over months at 5 g spirulina/day. Get ferritin + transferrin sat checked before stacking.
(cyclosporine, tacrolimus, methotrexate, biologics) — spirulina's immune-stimulating profile theoretically counteracts; clinical relevance unclear, but cauti…
variable vitamin K content can affect INR. Maintain consistent dose if combined; INR monitoring.
pause spirulina during flares pending rheumatology guidance.
What to Expect
- Week 1Tolerability and dose-response.
- Week 2-4Early effect window.
- Week 4-8Peak benefit assessment.
- Week 8+Cycle decision point.
Side Effects & Safety 7
Side Effects
- 1Digestive upset — bloating, gas, soft stool, mild nausea. Reduce dose, take with food, split into 2-3 doses.
- 2Green-to-black stool / urine tint — harmless pigment artifact. Not GI bleeding.
- 3"Detox-like" reactions in week 1 — mild headache, fatigue, brain fog. Often attributed to placebo or initial GI microbiome adjustment. Resolves within 5-10 days.
- 4Allergic reactions — itching, rash, oral tingling. Mostly from contaminating proteins in poorly-purified product. Discontinue.
- 5Insomnia (rare) — possibly from B-vitamin content or iron interaction. Switch to morning dosing.
- 6Loose stool / mild diarrhea at high doses (>10 g/day).
- 7Mild headache in week 1-2.
When to Stop
- Microcystin hepatotoxicity — if product contaminated with *Microcystis* cyanotoxins. Symptoms: nausea, RUQ pain, jaundice, transaminitis. Chronic low-dose exposure linked to liver-cancer risk in epidemiology. Hard preventive measure: buy only third-party-microcystin-tested product (Cyanotech, Earthrise, Now Foods with COA, etc.).
- Heavy-metal exposure — arsenic, lead, cadmium, mercury can accumulate. Open-pond cultivation is the highest-risk source. Hawaiian Pacifica (closed pond, regular COA) and EU/Japanese third-party-tested brands are the cleanest. Some 2024 surveillance studies found 10-30% of retail spirulina exceeded EU heavy-metal limits. Cumulative exposure over years at 5g/day from a contaminated batch could approach occupational lead-exposure levels.
- Autoimmune flare — case reports of MS, lupus, RA, dermatomyositis exacerbations. The phycocyanin-driven immune stimulation (NK + IL-2 + macrophage upregulation) is theoretically problematic in active autoimmune. Caution / avoid in autoimmune-active patients. Consult rheumatology if on immunomodulators.
- Iron overload in hemochromatosis or transfusion-dependent populations. 5 g/day adds ~1.5 mg iron — usually not enough alone to push overload, but stacking with multivitamin + iron supplement + red meat diet can.
- Phenylketonuria (PKU) — high phenylalanine content (~5% of protein). 5 g spirulina ≈ 140 mg phenylalanine, exceeding daily limits for many PKU patients. Absolute contraindication.
- Anaphylaxis to spirulina or cross-reactive shrimp/krill allergy — rare; documented case reports.
- No strong contraindication for clean-source spirulina at 1-3 g/day. Some clinicians and guidelines advise caution due to microcystin/heavy-metal contamination potential being more consequential during fetal/infant development. If used during pregnancy, only Hawaiian Pacifica or equivalent COA-certified product.
- Weeks 1-2: GI adjustment — if persistent diarrhea, nausea, or vomiting, stop and consider contamination (rather than tolerance) as cause.
- First month: allergic reaction watch — any rash, swelling, oral tingling → stop.
- Chronic use (>6 months): liver enzyme check — annual ALT/AST especially if higher-dose use or sourced from non-third-party-tested product.
References
Serban et al. 2016 — Spirulina and plasma lipid meta-analysis
landmark lipid meta of 7 RCTs.
View StudyCingi et al. 2008 — Effects of spirulina on allergic rhinitis
Turkish double-blind RCT, 150 patients, the clinical-evidence cornerstone for allergic rhinitis.
View StudyKalafati et al. 2010 — Ergogenic + antioxidant effects of spirulina in humans
Greek crossover RCT in trained males, 6 g/day × 4 weeks.
View StudyKarkos et al. 2011 — Spirulina in clinical practice: evidence-based human applications
comprehensive review.
View StudyAyehunie et al. 1998 — Inhibition of HIV-1 replication by aqueous spirulina extract
in-vitro antiviral signal.
View StudyKhalafi et al. 2024 — Spirulina supplementation and BP: GRADE meta-analysis
modern BP meta-analysis with GRADE evidence-grading.
View Study2025 systematic meta — Spirulina cardiovascular impacts (35 RCTs)
broadest CV-outcome synthesis to date.
View Study2025 meta — Spirulina alone or with exercise on cardiometabolic health (23 RCTs)
overweight/obese population, exercise synergy data.
View Study2025 GRADE dose-response meta — Spirulina + body composition (17 RCTs)
body weight, BMI, body fat percentage.
View StudyHatami et al. 2023 — Spirulina lipid profile GRADE dose-response meta (20 RCTs)
dose-response curves for HDL/LDL/TC/TG.
View StudyMao et al. 2005 — Spirulina dietary supplement IL-4 cytokine reduction in allergic rhinitis
mechanism for the Cingi finding.
View StudyMazokopakis et al. 2014 — Hepatoprotective + hypolipidemic effects of spirulina in NAFLD
Cretan pilot.
View StudyBaicus et al. 2007 — Spirulina did not ameliorate idiopathic chronic fatigue (N-of-1 trials)
negative finding for chronic fatigue indication.
View StudyNgo-Matip et al. 2015 — Spirulina + HIV-1 immune outcomes (Cameroon trial)
adjunctive nutrition support.
View StudyAlgae Supplementation for Exercise Performance review (Spirulina + Chlorella)
2022 antioxidant/anti-inflammatory/immunomodulatory systematic review in athletes.
View StudyMicrobiota and Cyanotoxin Content of Retail Spirulina Supplements (2023)
surveillance study on microcystin contamination.
View StudyMicrocystins and Cyanobacterial Contaminants in French Spirulina Production (2023)
additional contamination surveillance.
View StudyHeavy Metal Analysis in Commercial Spirulina Products
older surveillance on As/Pb/Hg/Cd.
View StudyOregon State LPI — Cyanobacteria / phycocyanin micronutrient information center
academic micronutrient reference.
View StudyWikipedia — Spirulina (dietary supplement) 2026
) — general reference with contamination + regulatory detail.
View StudyANSES (French food safety agency) — Spirulina safety opinion
official regulatory perspective on contamination risk.
View StudyNutrex Hawaii / Cyanotech product COA pages
vendor reference, COA availability.
View StudyEarthrise Nutritionals product pages
vendor reference for premium-tier US sourcing.
View StudyLatest research
- metaSpirulina supplementation and blood pressure — GRADE-assessed meta-analysis of RCTsPooled SBP -4.41 mmHg (95% CI -6.74 to -2.07), DBP -2.84 mmHg (95% CI -4.65 to -1.03). Larger effect with baseline BP ≥120/80, hypertensives, >50yo, and >8-week interventions. GRADE: moderate certainty for SBP, low-moderate for DBP.
- metaSpirulina's impacts on cardiovascular health — systematic meta-analysis of 35 RCTs35-trial pooled analysis: spirulina improves glucose homeostasis, reduces SBP -3.85 mmHg (p=0.002), DBP -3.09 mmHg (p<0.001). Broadest CV-outcome synthesis to date — corroborates BP signal independent of population.
- metaSpirulina supplementation on body composition — GRADE dose-response meta-analysis17 RCTs: body weight -1.07 kg (WMD), BMI -0.40, body-fat-percent -0.84%. Effects small but statistically significant. Most likely mechanism: appetite/satiety modulation + thermogenic shift in fatty-acid oxidation.
How was your experience with this compound?
Anonymous · one vote per session · results below at 5+ votes.
See something off?
Most of this wiki is AI-generated. Suggest a correction, dosing update, or new evidence — we review every submission.